oleic acid has been researched along with Melanoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ammendolia, MG; Bellenghi, M; Carafa, M; Carè, A; Forte, J; Hanieh, PN; Marianecci, C; Mattia, G; Pontecorvi, G; Puglisi, R; Rinaldi, F; Tirelli, V | 1 |
| Azmi, MN; Fajriah, S; Farabi, K; Harneti, D; Herlina, T; Hidayat, AT; Maharani, R; Mayanti, T; Sari, AP; Shiono, Y; Supratman, U | 1 |
| Durham, AB; Gu, Z; Martin-Sandoval, MS; Mathews, TP; McCormick, ML; Mitchell, EC; Morrison, SJ; Ramesh, V; Shen, B; Spitz, DR; Tasdogan, A; Ubellacker, JM; Zhao, Z | 1 |
| Du, J; Heath, JR; Lee, D; Levine, RD; Miao, K; Ng, AHC; Qian, C; Ribas, A; Su, Y; Wei, L; Wijker, RS; Yuan, D | 1 |
| Coelho, JMP; Faísca, P; Ferreira, D; Ferreira, H; Ferreira-Gonçalves, T; Figueiredo, IV; Gaspar, MM; Lopes, J; Reis, CP; Rodrigues, CMP; Silva, CO; Viana, AS | 1 |
| Lee, BJ; Tran, PH; Tran, TT; Yoon, TJ | 1 |
| D'Oca, MGM; de Moraes, MM; Piovesan, LA; Teixeira, WKO; Treptow, TGM; Votto, APS | 1 |
| Bellenghi, M; Bottero, L; Carè, A; Colombo, MP; De Feo, A; Denaro, M; Errico, MC; Felicetti, F; Felli, N; Gesumundo, C; Mattia, G; Pasquini, L; Pedini, F; Petrini, M; Puglisi, R; Sangaletti, S; Tripodo, C | 1 |
| Hamada, T; Insin, N; Palaga, T; Pan-In, P; Sangphech, N; Seemork, J; Shigyou, K; Tree-Udom, T; Wanichwecharungruang, S | 1 |
| Geilen, CC; Müller, C; Riebeling, C | 1 |
| Conway, BR; Du, L; Nimmannit, U; Suppasansatorn, P; Wang, Y | 1 |
| Jaffe, BM; Simmet, T | 1 |
12 other study(ies) available for oleic acid and Melanoma
| Article | Year |
|---|---|
pH-responsive oleic acid based nanocarriers: Melanoma treatment strategies.
Topics: Drug Carriers; Humans; Hydrogen-Ion Concentration; Melanoma; Nanoparticles; Oleic Acid | 2022 |
Dammarane-Type Triterpenoid from the Stem Bark of
Topics: Aglaia; Antineoplastic Agents; Breast Neoplasms; Dammaranes; Esters; Female; Humans; Ketones; Melanoma; Meliaceae; Molecular Structure; Oleic Acid; Plant Bark; Triterpenes | 2022 |
Lymph protects metastasizing melanoma cells from ferroptosis.
Topics: Animals; Cell Survival; Coenzyme A Ligases; Female; Ferroptosis; Glutathione; Humans; Iron; Lymph; Male; Melanoma; Mice; Neoplasm Metastasis; Oleic Acid; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase; Principal Component Analysis | 2020 |
Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells.
Topics: Apoptosis; Cell Line, Tumor; Fatty Acids; Humans; Lipid Droplets; Lipid Metabolism; Lipidomics; Lipids; Melanoma; Metabolomics; Microscopy; Oleic Acid; Spectrum Analysis, Raman; Stearoyl-CoA Desaturase; Transcriptome | 2020 |
Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.
Topics: Animals; Cell Line, Tumor; Epidermal Growth Factor; Gold; Humans; Low-Level Light Therapy; Male; Melanoma; Metal Nanoparticles; Mice, SCID; Multifunctional Nanoparticles; Oleic Acid; Proof of Concept Study; Skin Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Fattigation-platform theranostic nanoparticles for cancer therapy.
Topics: Animals; Cell Line, Tumor; Coated Materials, Biocompatible; Gelatin; Magnetite Nanoparticles; Melanoma; Mice; Neoplasms, Experimental; Oleic Acid; Paclitaxel; Silicon Dioxide; Theranostic Nanomedicine | 2017 |
Fatty-monastrol derivatives and its cytotoxic effect against melanoma cell growth.
Topics: Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Structure; Oleic Acid; Palmitic Acid; Pyrimidines; Structure-Activity Relationship; Thiones | 2017 |
SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.
Topics: Cathepsin B; Cell Line, Tumor; Disease Progression; Down-Regulation; Fatty Acids; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Intracellular Space; Melanocytes; Melanoma; Oleic Acid; Osteonectin; Stearoyl-CoA Desaturase | 2015 |
Shape Effect on Particle-Lipid Bilayer Membrane Association, Cellular Uptake, and Cytotoxicity.
Topics: Carcinoma; Cell Line, Tumor; Cell Membrane; Computer Simulation; Cytosol; Endocytosis; Flow Cytometry; Hep G2 Cells; Humans; Lanthanoid Series Elements; Lipid Bilayers; Liposomes; Liver Neoplasms; Melanoma; Microscopy, Electron, Transmission; Nanoparticles; Oleic Acid; Particle Size; Polyethylene Glycols | 2015 |
Expression and regulation of phospholipase D isoenzymes in human melanoma cells and primary melanocytes.
Topics: Adenosine Diphosphate; ADP-Ribosylation Factors; Alternative Splicing; Blotting, Western; Cell Division; Cell Line, Tumor; Cells, Cultured; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation, Enzymologic; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Humans; Immunoblotting; Melanocytes; Melanoma; Neoplasm Metastasis; Oleic Acid; Phorbol Esters; Phospholipase D; Protein Isoforms; Protein Kinase C; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA; RNA, Messenger | 2003 |
Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents, Alkylating; Dacarbazine; Detergents; Drug Carriers; Drug Delivery Systems; Emulsions; Esters; In Vitro Techniques; Melanoma; Mice; Mice, Hairless; Myristates; Oleic Acid; Permeability; Pharmaceutical Vehicles; Polyethylene Glycols; Prodrugs; Rats; Skin Absorption; Skin Neoplasms; Solubility; Temozolomide; Vitamin E | 2007 |
Inhibition of B-16 melanoma growth in vitro by prostaglandin D2.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; DNA, Neoplasm; Female; Humans; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasms, Experimental; Oleic Acid; Oleic Acids; Prostaglandin D2; Prostaglandins; Prostaglandins D; RNA, Neoplasm; Time Factors | 1983 |